Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets

ZIVOW (ZIVOW)

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
P/E (TTM)
EPS
Div Yield
52W Range
$0.00–$0.00
Beta
0.06

Company overview

Live quote temporarily unavailable — press releases and news are still shown below.

ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.

Peers in industry

ZIVOW has no peer companies in this window.

Recent press releases

March 2026

4 months ago8-K

Zivo Bioscience, Inc. — 8-K Filing

ZIVOWZivo Bioscience, Inc.

# 🧾 What This Document Is This is an **8-K filing**, which is a report companies file with the SEC to announce major events that shareholders should know about. In this case, ZIVO Bioscience is announcing a **huge strategic shift**: its Board of Directors has decided to *voluntarily* stop being a

Read summaryView on SEC EDGAR

SEC filings

All filings →
1 recent filing shown in the timeline above. View all SEC filings →

ZIVOW has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30

People at ZIVOW

All people →

No officers or directors have been indexed for ZIVOW.

Quarterly financials

Full financials →
Revenue trend
03/25
NI -$4.2M
06/25
$53.4K
NI
09/25
$65.6K
NI -$1.0M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.27
Prior: $-0.43
Revenue sparkline